Literature DB >> 28658200

Critical Ischemia Times and the Effect of Novel Preservation Solutions HTK-N and TiProtec on Tissues of a Vascularized Tissue Isograft.

Franka Messner1, Theresa Hautz, Michael J F Blumer, Mario Bitsche, Elisabeth J Pechriggl, Martin Hermann, Bettina Zelger, Bernhard Zelger, Dietmar Öfner, Stefan Schneeberger.   

Abstract

BACKGROUND: We herein investigate critical ischemia times and the effect of novel preservation solutions such as new histidine-tryptophan-ketoglutarate (HTK-N) and TiProtec on the individual tissues of a rat limb isograft.
METHODS: Orthotopic hind-limb transplantations were performed in male Lewis rats after 2 hours, 6 hours, or 10 hours of cold ischemia (CI). Limbs were flushed and stored in HTK-N, TiProtec, HTK, or saline solution. Muscle, nerve, vessel, skin, and bone samples were procured on day 10 for histology, immunohistochemistry, confocal and electron microscopy, and quantitative real-time polymerase chain reaction analysis.
RESULTS: Histomorphology of the muscle showed a mainly perivascular inflammatory infiltrate, fibrotic degeneration, and neovascularization after 6 hours and 10 hours of CI. However, centrally aligned nuclei observed in muscle fibers suggest for muscle regeneration in these samples. In addition to Wallerian degeneration, nerve injury was significantly aggravated (P = 0.032) after prolonged CI. Proinflammatory and regulatory cytokines were most significantly upregulated after 2-hour CI. Our data suggest no superiority of novel perfusates HTK-N and TiProtec in terms of tissue preservation, compared with HTK and saline.
CONCLUSIONS: Limiting CI time for less than 6 hours is the most significant factor to reduce tissue damage in vascularized tissue transplantation. Signs of muscle regeneration give rise that ischemic muscle damage in limb transplantation might be reversible to a certain extent.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28658200     DOI: 10.1097/TP.0000000000001845

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Successful 18-h acellular extracorporeal perfusion and replantation of porcine limbs - Histology versus nerve stimulation.

Authors:  Anne Sophie Kruit; Kaj Brouwers; Dominique van Midden; Her Zegers; Erik Koers; Nens van Alfen; Stefan Hummelink; Dietmar J O Ulrich
Journal:  Transpl Int       Date:  2021-01-05       Impact factor: 3.782

2.  Evaluation of Early Markers of Ischemia-reperfusion Injury and Preservation Solutions in a Modified Hindlimb Model of Vascularized Composite Allotransplantation.

Authors:  Sara Rostami; Michael Xu; Shaishav Datta; Siba Haykal
Journal:  Transplant Direct       Date:  2021-12-13

Review 3.  Improving the ischemia-reperfusion injury in vascularized composite allotransplantation: Clinical experience and experimental implications.

Authors:  Jiqiang He; Umar Zeb Khan; Liming Qing; Panfeng Wu; Juyu Tang
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

4.  Myogenic progenitor cell transplantation for muscle regeneration following hindlimb ischemia and reperfusion.

Authors:  Franka Messner; Marco Thurner; Stefan Schneeberger; Theresa Hautz; Jule Müller; Michael Blumer; Julia Hofmann; Rainer Marksteiner; Sebastien Couillard-Despres; Jakob Troppmair; Dietmar Öfner
Journal:  Stem Cell Res Ther       Date:  2021-02-24       Impact factor: 6.832

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.